Chinese expert consensus on management of dyslipidemia in the elderly
- VernacularTitle:老年人血脂异常管理中国专家共识
- Author:
Meilin LIU
1
;
Yumeng ZHANG
;
Zhifang FU
;
Ping YE
;
Yifang GUO
;
Fang WANG
;
Qing HE
;
Jianjun LI
;
Xiaowei YAN
;
Yuhua LIAO
;
Xiaofang ZHOU
;
Xiping TUO
;
Zhaohui WANG
Author Information
- Keywords: Aged; Dyslipidemias; Statins; Atherosclerosis
- From: Chinese Journal of Internal Medicine 2022;61(10):1095-1118
- CountryChina
- Language:Chinese
- Abstract: Dyslipidemia is an important risk factor of atherosclerotic cardiovascular disease (ASCVD). Statins delay the occurrence and development of ASCVD, and reduce the risk of cardiovascular events and death. Due to safety concerns, there exist insufficient use of lipid-lowering agents and a high withdrawal rate of the agents in the elderly. To promote the prevention and treatment of ASCVD, this expert consensus is issued and focuses on the management of dyslipidemia of Chinese elderly basing on the clinical evidence of the use of lipid-lowering drugs by the elderly, and the lipid management guidelines and expert consensus recommendations at home and abroad.
